Pharmaceuticals and Healthcare Reports Anti-Neutrophil Cytoplasmic Antibody-Associated Va | Page 2

Radiant Insights's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Drug profiles featured in the
report undergoes periodic review following a stringent set of processes to ensure that all the profiles
are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Request a Sample Copy of This Report @ http://www.radiantinsights.com/research/anti-
neutrophil-cytoplasmic-antibody-associated-vasculitis-anca-vasculitis-pipeline-review-
h2-2016/request-sample
Scope
- The report provides a snapshot of the global therapeutic landscape of Anti-Neutrophil Cytoplasmic
Antibody-Associated Vasculitis (ANCA Vasculitis)
- The report reviews pipeline therapeutics for Anti-Neutrophil Cytoplasmic Antibody-Associated
Vasculitis (ANCA Vasculitis) by companies and universities/research institutes based on information
derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-
registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved Anti-Neutrophil Cytoplasmic Antibody-Associated
Vasculitis (ANCA Vasculitis) therapeutics and enlists all their major and minor projects
- The report assesses Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Anti-Neutrophil Cytoplasmic
Antibody-Associated Vasculitis (ANCA Vasculitis)
Follow Us: